A unique Market Research approach to inform rare disease education.

The Challenge.

One of the common challenges orphan drug makers face is how to improve the diagnostic process. In a landscape where every patient counts, ensuring an optimal diagnostic process is critical. However, rare diseases can present in complex, multisystemic ways, often leading patients down multiple incorrect paths before receiving a correct diagnosis – if they ever get diagnosed at all.

Download the report to see our criteria for your MR project:

• Are physicians seeing patients who could have the rare disease of interest?
• Are there challenges with effective diagnosis?
• Is the specialty of interest willing to be involved?